Guardant Health (GH) Gross Profit (2024 - 2026)

Guardant Health has reported Gross Profit for 3 years, with the latest figure at $219.0 million in Q2 2026.

• Quarterly Gross Profit rose 45.16% year-over-year to $219.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $769.2 million (up 47.68% YoY) and the FY2025 annual result came in at $633.0 million, up 40.91% from the prior year.
• Gross Profit advanced to $219.0 million in Q2 2026 per GH's latest filing, from $196.7 million in the prior quarter.
• Over five years, Gross Profit peaked at $219.0 million in Q2 2026 and troughed at $103.2 million in Q1 2024.
• A 3-year average of $149.8 million and a median of $139.8 million in 2025 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2025 and 2026: Gross Profit increased 24.76% in 2025, then jumped 52.81% in 2026.
• Over 3 years, Gross Profit stood at $124.2 million in 2024, then jumped by 46.33% to $181.8 million in 2025, then increased by 20.5% to $219.0 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $219.0 million, $196.7 million, and $181.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.